LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 65

Search options

  1. Article ; Online: Racial, ethnic, and healthcare disparities in rheumatoid arthritis.

    Yip, Kevin / Navarro-Millán, Iris

    Current opinion in rheumatology

    2020  Volume 33, Issue 2, Page(s) 117–121

    Abstract: Purpose of review: This review highlights the available data describing racial and ethnic health disparities among patients with rheumatoid arthritis in the United States from an epidemiological, disease activity, and wider socioeconomic standpoint.: ... ...

    Abstract Purpose of review: This review highlights the available data describing racial and ethnic health disparities among patients with rheumatoid arthritis in the United States from an epidemiological, disease activity, and wider socioeconomic standpoint.
    Recent findings: Despite centralized government initiatives to include more underrepresentative minority populations into research, many of the studies that examined rheumatoid arthritis still fail to include sizeable cohorts of races or ethnic groups other than whites. Evidence is slowly mounting that individual, provider, and system-level barriers exist and contribute to unequal care that leads to poorer outcomes amongst patients with rheumatoid arthritis. As rheumatoid arthritis is a progressive disease, early treatment is crucial to delay functional decline - a narrow window for many minority patients who are disproportionality affected by disability.
    Summary: To combat the inequality that exists amongst rheumatoid arthritis patients we must focus on why discrepancies exist on every level, system, physician, patient, and illness. Further research is needed to tease the complex interplay between race, social economic status, medical access, and outcomes to explain the disparities found in rheumatoid arthritis.
    MeSH term(s) Arthritis, Rheumatoid/epidemiology ; Arthritis, Rheumatoid/therapy ; Ethnicity ; Health Status Disparities ; Healthcare Disparities ; Humans ; Minority Groups ; Socioeconomic Factors ; United States/epidemiology
    Language English
    Publishing date 2020-11-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000782
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reply.

    Navarro-Millán, Iris / Crow, Mary K

    Arthritis & rheumatology (Hoboken, N.J.)

    2021  Volume 73, Issue 3, Page(s) 549–550

    MeSH term(s) COVID-19 ; Humans ; Interleukin 1 Receptor Antagonist Protein ; Liver ; SARS-CoV-2
    Chemical Substances Interleukin 1 Receptor Antagonist Protein
    Keywords covid19
    Language English
    Publishing date 2021-01-29
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.41524
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lay Health Worker Interventions in Rheumatology: A Scoping Review.

    Creasman, Megan W / Hargrove, Mackenzie B / Domínguez Páez, Yuliana / Demetres, Michelle / Lieber, Sarah / Kasturi, Shanthini / Safford, Monika M / Navarro-Millán, Iris

    Arthritis care & research

    2024  

    Abstract: Objective: To determine next steps for lay health worker (LHW) intervention research, specifically in patients with rheumatic musculoskeletal diseases (RMD), there is a need to establish what strategies have been effective for chronic disease management ...

    Abstract Objective: To determine next steps for lay health worker (LHW) intervention research, specifically in patients with rheumatic musculoskeletal diseases (RMD), there is a need to establish what strategies have been effective for chronic disease management thus far. The goal of this scoping review is to collate the literature of LHW interventions for adults with RMD to inform next steps for LHW research.
    Methods: A comprehensive literature search was performed in the following databases from inception - September 2021: Ovid MEDLINE, Ovid EMBASE, CINAHL, PsycINFO and The Cochrane Library. Studies retrieved were then screened for eligibility against predefined inclusion/exclusion criteria.
    Results: Twenty-two articles were eligible and included in this review. The most common RMD studied diseases, not mutually exclusive, were osteoarthritis (n=13), rheumatoid arthritis (n=9), and unspecified/other RMD (n=14). Most studies had a homogenous patient population enrolling White, non-Hispanic or Latina females over the age of sixty (n=13). Eight studies observed statistically significant results in the intervention arm compared to the control. Only one of these studies exhibited sustained treatment effects past one year.
    Conclusion: There are not enough data to conclude if LHW interventions have a positive, null, or negative effect in patients with RMD. Future LHW interventions should specify a priori hypotheses, be powered to detect statistical significance for primary outcomes, employ a theoretical framework, include an active control, describe training protocols for LHW, and increase minority representation, in order to establish the effectiveness of LHW for patients with RMD.
    Language English
    Publishing date 2024-04-03
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645059-3
    ISSN 2151-4658 ; 0893-7524 ; 2151-464X
    ISSN (online) 2151-4658
    ISSN 0893-7524 ; 2151-464X
    DOI 10.1002/acr.25341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A Novel Approach for Mixed-Methods Research Using Large Language Models: A Report Using Patients' Perspectives on Barriers to Arthroplasty.

    Mannstadt, Insa / Goodman, Susan M / Rajan, Mangala / Young, Sarah R / Wang, Fei / Navarro-Millán, Iris / Mehta, Bella

    ACR open rheumatology

    2024  

    Abstract: Objective: Mixed-methods research is valuable in health care to gain insights into patient perceptions. However, analyzing textual data from interviews can be time-consuming and require multiple analysts for investigator triangulation. This study aims ... ...

    Abstract Objective: Mixed-methods research is valuable in health care to gain insights into patient perceptions. However, analyzing textual data from interviews can be time-consuming and require multiple analysts for investigator triangulation. This study aims to explore a novel approach to investigator triangulation in mixed-methods research by employing a large language model (LLM) for analyzing data from patient interviews.
    Methods: This study compared the thematic analysis and survey generation performed by human investigators and ChatGPT-4, which uses GPT-4 as its backbone model, using data from an existing study that explored patient perceptions of barriers to arthroplasty. The human- and ChatGPT-4-generated themes and surveys were compared and evaluated based on their representation of salient themes from a predetermined topic guide.
    Results: ChatGPT-4 generated analogous dominant themes and a comprehensive corresponding survey as the human investigators but in significantly less time. The survey questions generated by ChatGPT-4 were less precise than those developed by human investigators. The mixed-methods flowchart proposes integrating LLMs and human investigators as a supplementary tool for the preliminary thematic analysis of qualitative data and survey generation.
    Conclusion: By utilizing a combination of LLMs and human investigators through investigator triangulation, researchers may be able to conduct more efficient mixed-methods research to better understand patient perspectives. Ethical and qualitative implications of using LLMs should be considered.
    Language English
    Publishing date 2024-03-07
    Publishing country United States
    Document type Journal Article
    ISSN 2578-5745
    ISSN (online) 2578-5745
    DOI 10.1002/acr2.11662
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The role of immunomodulatory medications in the treatment of COVID-19.

    Sattui, Sebastian E / Crow, Mary K / Navarro-Millán, Iris

    Current opinion in rheumatology

    2021  Volume 33, Issue 5, Page(s) 431–445

    Abstract: Purpose of review: Given the role of inflammation in severe forms of COVID-19, glucocorticoids and disease-modifying antirheumatic drugs (DMARDs) have been assessed as potential COVID-19 therapies.: Recent findings: Randomized controlled trials (RCTs) ...

    Abstract Purpose of review: Given the role of inflammation in severe forms of COVID-19, glucocorticoids and disease-modifying antirheumatic drugs (DMARDs) have been assessed as potential COVID-19 therapies.
    Recent findings: Randomized controlled trials (RCTs) have shown that glucocorticoids reduce mortality in severe COVID-19. RCTs of DMARDs have shown mixed results varying on intervention and inclusion criteria. DMARDs, including colchicine or biologic agents, may improve COVID-19 outcomes in specific patient populations.
    Summary: Glucocorticoids are an effective treatment for the management of severe COVID-19. Further studies are needed to better define the patient populations who could benefit from DMARD use, as well as provide guidance regarding the timing of these interventions.
    MeSH term(s) Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/drug therapy ; Biological Factors/therapeutic use ; Humans ; SARS-CoV-2 ; COVID-19 Drug Treatment
    Chemical Substances Antirheumatic Agents ; Biological Factors
    Language English
    Publishing date 2021-09-07
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: "Frailty" bei Spondylitis ankylosans und Psoriasis-Arthritis

    Lieber, Sarah B. / Navarro-Millan, Iris / Rajan, Mangala

    Morbus-Bechterew-Journal

    2023  Volume 44, Issue 172, Page(s) 14

    Language German
    Document type Article
    ZDB-ID 2119820-2
    ISSN 1861-2105
    Database Current Contents Medicine

    More links

    Kategorien

  7. Article ; Online: Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment.

    Jagpal, Aprajita / Navarro-Millán, Iris

    BMC rheumatology

    2018  Volume 2, Page(s) 10

    Abstract: Cardiovascular disease (CVD) is markedly increased in patients with rheumatoid arthritis partly due to accelerated atherosclerosis from chronic inflammation. Traditional cardiovascular risk factors such as hypertension, hyperlipidemia, smoking, diabetes ... ...

    Abstract Cardiovascular disease (CVD) is markedly increased in patients with rheumatoid arthritis partly due to accelerated atherosclerosis from chronic inflammation. Traditional cardiovascular risk factors such as hypertension, hyperlipidemia, smoking, diabetes mellitus and physical inactivity are also highly prevalent among patients with rheumatoid arthritis (RA) and contribute to the CVD risk. The impact of traditional risk factors on the CVD risk appears to be different in the RA and non-RA population. However, hyperlipidemia, diabetes mellitus, body mass index and family history of CVD influence the CVD risk in RA patients the same way they do for the non-RA population. Despite that, screening and treatment of these risk factors is suboptimal among patients with RA. Recent guidelines from the European League Against Rheumatism (EULAR) recommend aggressive management of traditional risk factors in addition to RA disease activity control to decrease the CVD risk. Several CVD risk calculators are available for clinical use to stratify a patients' risk of developing a CVD event. Most of these calculators do not account for RA as a risk factor; thus, a multiplication factor of 1.5 is recommended to predict the risk more accurately. In order to reduce CVD in the RA population, national guidelines for the prevention of CVD should be applied to manage traditional risk factors in addition to aggressive control of RA disease activity. While current data suggests a protective effect of non-biologic disease modifying anti-rheumatic drugs (DMARDs) and biologics on cardiovascular events among patients with RA, more data is needed to define this effect more accurately.
    Language English
    Publishing date 2018-04-11
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2918121-5
    ISSN 2520-1026 ; 2520-1026
    ISSN (online) 2520-1026
    ISSN 2520-1026
    DOI 10.1186/s41927-018-0014-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries.

    Lieber, Sarah B / Nahid, Musarrat / Navarro-Millán, Iris / Rajan, Mangala / Sattui, Sebastian E / Mandl, Lisa A

    Lupus science & medicine

    2023  Volume 10, Issue 2

    Abstract: Objective: Frailty is a risk factor for adverse health in adults with SLE, including those <65 years. Emergency department (ED) utilisation is high in adults with SLE, but to our knowledge, whether frailty is associated with ED use is unknown. In a ... ...

    Abstract Objective: Frailty is a risk factor for adverse health in adults with SLE, including those <65 years. Emergency department (ED) utilisation is high in adults with SLE, but to our knowledge, whether frailty is associated with ED use is unknown. In a large administrative claims dataset, we assessed risk of ED utilisation among frail adults with SLE ≤65 years of age relative to non-frail adults ≤65 years of age with SLE.
    Methods: Using the MarketScan Medicaid subset from 2011 to 2015, we identified beneficiaries 18-65 years with SLE (≥3 SLE International Classification of Diseases, Ninth Revision codes ≥30 days apart). Comparators without a systemic rheumatic disease (SRD) were matched 4:1 on age and gender. Frailty status in 2011 was determined using two claims-based frailty indices (CFIs). We compared risk of recurrent ED utilisation among frail and non-frail beneficiaries with SLE using an extension of the Cox proportional hazard model for recurrent events data.
    Results: Of 2262 beneficiaries with SLE and 9048 non-SRD comparators, 28.8% and 11.6% were frail, respectively, according to both CFIs. Compared with non-frail beneficiaries with SLE, frail beneficiaries with SLE had significantly higher hazard of recurrent ED use (HR 1.75, 95% CI 1.48 to 2.08).
    Conclusion: Frailty increased hazard of recurrent ED visits in frail adults ≤65 years of age with SLE relative to comparable non-frail adults with SLE. Frailty is a potential target for efforts to improve quality of care in SLE.
    MeSH term(s) United States/epidemiology ; Adult ; Humans ; Aged ; Lupus Erythematosus, Systemic/complications ; Lupus Erythematosus, Systemic/epidemiology ; Frailty/complications ; Frailty/epidemiology ; Medicaid ; Emergency Service, Hospital ; Data Analysis
    Language English
    Publishing date 2023-07-27
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2779620-6
    ISSN 2053-8790
    ISSN 2053-8790
    DOI 10.1136/lupus-2023-000905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply.

    Navarro-Millán, Iris / Goyal, Parag / Safford, Monika M

    Rheumatology (Oxford, England)

    2019  Volume 59, Issue 2, Page(s) 454–455

    MeSH term(s) Antirheumatic Agents ; Arthritis, Rheumatoid ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipids
    Chemical Substances Antirheumatic Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipids
    Language English
    Publishing date 2019-12-19
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kez489
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.

    Navarro-Millán, Iris / Goyal, Parag / Safford, Monika M

    Rheumatology (Oxford, England)

    2018  Volume 58, Issue 6, Page(s) 933–934

    MeSH term(s) Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/blood ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/drug therapy ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Lipids/blood ; Practice Guidelines as Topic
    Chemical Substances Antirheumatic Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipids
    Language English
    Publishing date 2018-09-10
    Publishing country England
    Document type Editorial ; Research Support, N.I.H., Extramural
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/key302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top